This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Difference in immune cell profile in blood between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in cytokine production of mononuclear cells to fungal stimulation in blood between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in function of blood neutrophils between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in in immune cell profile in BAL fluid between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in cytokine production of mononuclear cells to fungal stimulation in BAL fluid between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in function of BAL fluid neutrophils between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)
Difference in pathological hallmarks between influenza and non-influenza CAPIV patients at ICU.
Timeframe: through study completion, after 3 influenza seasons (3 years)